cerrar
Tagged with strategy

Interview: Christian Dyvig, CEO, Lundbeck Foundation
The CEO of one of Denmark’s largest foundations talks about the merits of the foundation model, and the current strategies of both Lundbeck and ALK…

Interview: Roberto Bellini, President & CEO, Bellus Health,…
The CEO of Bellus Health outlines his strategy since 2010 to change the focus of the company from Alzheimer’s to a niche disease, AA amyloidosis, as…

Colombia’s Law 100: from 93 to infinity?
President Santos appointed economist Alejandro Gaviria as the new Minister of Health and Social Protection in September 2012. Gaviria‰Ûªs priority…

Interview: Raphael Hofstein, President & CEO, MaRS…
The CEO of MaRS Innovation, a commercialization incubator created by 16 of Toronto's best research institutions and supported by the government,…

Nicolas Marceau – Minister of Finance & Economy,…
Minister Marceau addresses the changes in policy in Quebec relating to the pharmaceutical and life sciences sectors, and the incentives in place to…

Interview: Paul Glover, Associate Deputy Minister, Health Canada
A perspective from Canada’s national health body on the future of medicine in the 21st century, from the shift to personalized medicine to…

Interview: Johnsee Lee, Chairman, Development Center for…
A leading figure in the Taiwanese pharmaceutical sector, Lee divulges the practicalities behind ECFA, the free trade agreement that was signed between…

Colombia: Confidence in uncertainty
Under the administration of President Juan Manuel Santos, Colombia is focusing on bolstering the commercial sector. While this is good news for the…

Interview: Tom Rönnlund, General Manager Nordic & Baltic…
Tom Rönnlund discusses the current state of the pharmaceutical industry in the Nordics in this time of austerity, and offers opinions on reference…

The 3 T’s: Positioning Ireland for FDI
What makes Ireland attractive for FDI? As the former general manager of Genzyme‰Ûªs Waterford site, Pat O‰ÛªSullivan explains that a…

Ireland: up the ladder
Lilly set up in Ireland three decades ago by purchasing a farm. In its early days, the operation produced intermediaries for small-molecule drugs.…

Ireland: Cut costs or add value?
It is widely acknowledged that pharmaceutical manufacturing operations have entered into a period of significant cost reduction. Service providers…
We use cookies to ensure that we give you the best experience on our site. For more info

See our Cookie Privacy Policy Here